Target
Urokinase-type plasminogen activator
Ligand
BDBM50099896
Substrate
n/a
Meas. Tech.
ChEBML_213135
Ki
108±n/a nM
Citation
 Subasinghe, NLIllig, CHoffman, JRudolph, MJWilson, KJSoll, RRandle, TGreen, DLewandowski, FZhang, MBone, RSpurlino, JDesJarlais, RDeckman, IMolloy, CJManthey, CZhou, ZSharp, CMaguire, DCrysler, CGrasberger, B Structure-based design, synthesis and SAR of a novel series of thiopheneamidine urokinase plasminogen activator inhibitors. Bioorg Med Chem Lett 11:1379-82 (2001) [PubMed]  Article 
Target
Name:
Urokinase-type plasminogen activator
Synonyms:
3.4.21.73 | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase | Urokinase-type plasminogen activator (uPA) | Urokinase-type plasminogen activator chain B | Urokinase-type plasminogen activator long chain A | Urokinase-type plasminogen activator short chain A | Urokinase-type plasminogen activator/surface receptor | uPA
Type:
Enzyme
Mol. Mass.:
48528.62
Organism:
Homo sapiens (Human)
Description:
P00749
Residue:
431
Sequence:
MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKLLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL
  
Inhibitor
Name:
BDBM50099896
Synonyms:
4-[4-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-thiazol-2-yl]-5-methylsulfanyl-thiophene-2-carboxamidine | CHEMBL285325
Type:
Small organic molecule
Emp. Form.:
C17H15N3O2S3
Mol. Mass.:
389.515
SMILES:
CSc1sc(cc1-c1nc(cs1)-c1ccc2OCCOc2c1)C(N)=N
Structure:
Search PDB for entries with ligand similarity: